BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 144126)

  • 1. Changes in allosteric properties of phosphofructokinase bound to erythrocyte membranes.
    Karadsheh NS; Uyeda K
    J Biol Chem; 1977 Nov; 252(21):7418-20. PubMed ID: 144126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Properties of erythrocyte phosphofructokinase in normal humans].
    Mandereau J; Boivin P
    Biochimie; 1973; 55(11):1341-51. PubMed ID: 4364375
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of 2,3-diphosphoglycerate concentration on the alkaline fragility of phosphofructokinase-deficient canine erythrocytes.
    Harvey JW; Sussman WA; Pate MG
    Comp Biochem Physiol B; 1988; 89(1):105-9. PubMed ID: 2965634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and kinetic properties of phosphofructokinase from Rana ridibunda erythrocytes.
    Kaloyianni M; Kotinis K; Gounaris EG
    Comp Biochem Physiol Biochem Mol Biol; 1994 Mar; 107(3):479-87. PubMed ID: 7749616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cortisol on erythrocyte and reticulocyte enzymes: modulation of phosphofructokinase properties.
    Kwiatkowska D; Szajerka G; Kwiatkowska J
    Arch Immunol Ther Exp (Warsz); 1983; 31(3):381-7. PubMed ID: 6228205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic properties of the phosphofructokinase from erythrocytes of rats and rabbits. 2. The influence of effectors under nearly cellular conditions.
    Kühn B; Jacobasch G; Gerth C; Rapoport SM
    Eur J Biochem; 1974 Apr; 43(3):443-50. PubMed ID: 4275501
    [No Abstract]   [Full Text] [Related]  

  • 7. Activation of rat erythrocyte phosphofructokinase by AMP and by non-physiological concentrations of cyclic AMP.
    Pinilla M; Luque J
    Mol Cell Biochem; 1977 May; 15(3):219-23. PubMed ID: 196180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of phosphofructokinase and aldolase with the membrane of the intact erythrocyte.
    Jenkins JD; Madden DP; Steck TL
    J Biol Chem; 1984 Aug; 259(15):9374-8. PubMed ID: 6235228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Ca2+ on erythrocyte membrane skeleton-bound phosphofructokinase, ATP levels, and hemolysis.
    Assouline-Cohen M; Beitner R
    Mol Genet Metab; 1999 Jan; 66(1):56-61. PubMed ID: 9973548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of free Mg2+ on the kinetics of human erythrocyte phosphofructokinase.
    Etiemble J; Simeon J; Picat C; Boivin P
    Biochimie; 1981 Jan; 63(1):61-5. PubMed ID: 6452173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of adrenal steroids on human erythrocyte phosphofructokinase.
    Kwiatkowska D; Szechiński J
    Arch Immunol Ther Exp (Warsz); 1986; 34(4):445-50. PubMed ID: 2948478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-association of human erythrocyte phosphofructokinase. Kinetic behaviour in dependence on enzyme concentration and mode of association.
    Wenzel KW; Kurganov BI; Zimmermann G; Yakovlev VA; Schellenberger W; Hofmann E
    Eur J Biochem; 1976 Jan; 61(1):181-90. PubMed ID: 128461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modifications in the allosteric properties of phosphofructokinase in rat erythrocytes and reticulocytes cross-linked with dimethyl suberimidate and 3,3'-dithiobispropionimidate.
    Pinilla M; Luque J; Tipton KF
    Biochim Biophys Acta; 1982 Apr; 702(2):254-61. PubMed ID: 6211194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific, reversible inactivation of phosphofructokinase by fructose-1,6-bisphosphatase. Involvement of adenosine 5'-triphosphate, oleate, and 3-phosphoglycerate.
    Proffitt RT; Sankaran L
    Biochemistry; 1976 Jun; 15(13):2918-25. PubMed ID: 181051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of phosphofructokinase with erythrocyte membranes.
    Higashi T; Richards CS; Uyeda K
    J Biol Chem; 1979 Oct; 254(19):9542-50. PubMed ID: 39927
    [No Abstract]   [Full Text] [Related]  

  • 16. Erythrocyte phosphofructokinase in rat strains with genetically determined differences in 2,3-diphosphoglycerate levels.
    Noble NA; Tanaka KR
    Biochem Genet; 1981 Feb; 19(1-2):61-73. PubMed ID: 6452873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinases of rabbit and human erythrocyte membranes. Solubilization and characterization.
    Hosey MM; Tao M
    Biochim Biophys Acta; 1977 Jun; 482(2):348-57. PubMed ID: 18184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of 2,3-DPG on red cell phosphofructokinase.
    Beutler E; Guinto E
    FEBS Lett; 1973 Nov; 37(1):21-2. PubMed ID: 4270992
    [No Abstract]   [Full Text] [Related]  

  • 19. Enzymes and glycolytic intermediates in the rabbit erythrocyte.
    Agar NS; Smith JE
    Enzyme; 1974; 17(4):205-9. PubMed ID: 4275950
    [No Abstract]   [Full Text] [Related]  

  • 20. A mathematical model for the influence of anionic effectors on the phosphofructokinase from rat erythrocytes.
    Otto M; Heinrich R; Jacobasch G; Rapoport S
    Eur J Biochem; 1977 Apr; 74(2):413-20. PubMed ID: 140047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.